Codexis Ownership
| CDXS Stock | USD 5.21 0.02 0.39% |
Shares in Circulation | First Issued 2007-03-31 | Previous Quarter 70.4 M | Current Value 72 M | Avarage Shares Outstanding 44.1 M | Quarterly Volatility 19.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Codexis |
Codexis Stock Ownership Analysis
About 80.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.88. Codexis had not issued any dividends in recent years. Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company was incorporated in 2002 and is headquartered in Redwood City, California. Codexis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 261 people. For more info on Codexis please contact Stephen MBBS at 650 421 8100 or go to https://www.codexis.com.Besides selling stocks to institutional investors, Codexis also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Codexis' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Codexis' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Codexis Quarterly Liabilities And Stockholders Equity |
|
Codexis Insider Trades History
Roughly 2.0% of Codexis are currently held by insiders. Unlike Codexis' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Codexis' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Codexis' insider trades
Codexis Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Codexis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Codexis backward and forwards among themselves. Codexis' institutional investor refers to the entity that pools money to purchase Codexis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Nuveen Asset Management, Llc | 2024-09-30 | 1.5 M | Millennium Management Llc | 2024-09-30 | 1.4 M | Kent Lake Capital Llc | 2024-06-30 | 1.3 M | Federated Hermes Inc | 2024-09-30 | 1.3 M | Assenagon Asset Management Sa | 2024-09-30 | 1.1 M | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 895.7 K | Abrdn Plc | 2024-09-30 | 800.4 K | Northern Trust Corp | 2024-09-30 | 589.9 K | Goldman Sachs Group Inc | 2024-09-30 | 555.1 K | Opaleye Management Inc | 2024-09-30 | 8.8 M | Casdin Capital, Llc | 2024-09-30 | 8.1 M |
Codexis Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Codexis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Codexis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Codexis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Codexis' latest congressional trading
Congressional trading in companies like Codexis, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Codexis by those in governmental positions are based on the same information available to the general public.
| 2018-05-08 | Representative Lamar Smith | Acquired Under $15K | Verify |
Codexis Outstanding Bonds
Codexis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Codexis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Codexis bonds can be classified according to their maturity, which is the date when Codexis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Codexis Corporate Filings
| 14th of November 2024 Other Reports | ViewVerify | |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 28th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 10th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Codexis Stock Analysis
When running Codexis' price analysis, check to measure Codexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Codexis is operating at the current time. Most of Codexis' value examination focuses on studying past and present price action to predict the probability of Codexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Codexis' price. Additionally, you may evaluate how the addition of Codexis to your portfolios can decrease your overall portfolio volatility.